CME Group (CME) Financials

$285.98 +1.62 (+0.57%)

Closing price 05/28/2025 04:00 PM Eastern

Extended Trading

$285.38 -0.61 (-0.21%)

As of 05/28/2025 07:49 PM Eastern

Annual Income Statements for CME Group

This table shows CME Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	3,482	3,186	2,657	2,617	2,105	4,233	1,961	4,063	1,534	1,247
Consolidated Net Income / (Loss)	3,526	3,226	2,691	2,637	2,106	4,232	1,962	4,063	1,534	1,247
Net Income / (Loss) Continuing Operations	3,526	3,226	2,691	2,637	2,106	4,232	1,964	4,063	1,534	1,247
Total Pre-Tax Income	4,541	4,154	3,490	3,374	2,722	2,690	2,778	2,526	2,288	1,957
Total Operating Income	3,932	3,436	3,016	2,645	2,637	2,588	2,608	2,311	2,201	1,989
Total Gross Profit	5,280	4,750	4,266	3,853	4,027	3,969	3,520	3,081	3,052	2,649
Total Revenue	6,130	5,579	5,019	4,690	4,884	4,868	4,309	3,645	3,595	3,327
Operating Revenue	6,130	5,579	5,019	4,690	4,884	4,868	4,309	3,645	3,595	3,269
Total Cost of Revenue	850	829	753	837	857	899	789	564	543	678
Operating Cost of Revenue	850	829	753	837	857	899	789	564	543	678
Total Operating Expenses	1,348	1,315	1,250	1,208	1,390	1,382	912	770	852	661
Selling, General & Admin Expense	400	421	379	393	482	535	493	314	393	247
Depreciation Expense	115	126	135	148	153	159	119	113	129	129
Amortization Expense	222	227	228	238	311	315	130	96	96	99
Other Operating Expenses / (Income)	611	542	509	430	443	374	171	248	233	185
Total Other Income / (Expense), net	610	718	474	728	85	102	170	216	87	-32
Interest Expense	161	159	163	167	166	178	158	117	124	117
Interest & Investment Income	4,430	5,572	2,500	553	373	815	898	661	252	130
Other Income / (Expense), net	-3,659	-4,695	-1,862	343	-122	-535	-570	-328	-41	-45
Income Tax Expense	1,016	927	799	737	616	574	814	-1,537	754	710
Basic Earnings per Share	$9.69	$8.87	$7.41	$7.30	$5.88	$5.93	$5.73	$12.00	$4.55	$3.71
Weighted Average Basic Shares Outstanding	359.39M	359.02M	358.71M	358.34M	357.76M	357.16M	342.34M	338.71M	337.50M	336.22M
Diluted Earnings per Share	$9.67	$8.86	$7.40	$7.29	$5.87	$5.91	$5.71	$11.94	$4.53	$3.69
Weighted Average Diluted Shares Outstanding	359.94M	359.50M	359.18M	358.93M	358.52M	358.24M	343.74M	340.23M	338.97M	337.89M
Weighted Average Basic & Diluted Shares Outstanding	360.36M	359.99M	359.72M	359.40M	359.01M	357.16M	342.34M	340.39M	339.65M	338.42M
Cash Dividends to Common per Share	$10.40	-	-	$6.85	$5.90	$5.50	$4.55	$6.14	$5.65	$4.90

This table shows CME Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	956	830	913	883	855	774	750	778	884	604	680
Consolidated Net Income / (Loss)	956	875	913	883	855	815	750	778	884	638	680
Net Income / (Loss) Continuing Operations	956	875	913	883	855	815	750	778	884	638	680
Total Pre-Tax Income	1,245	1,097	1,177	1,155	1,113	1,006	974	1,016	1,157	827	880
Total Operating Income	1,108	947	1,024	1,001	960	863	820	839	914	668	739
Total Gross Profit	1,436	1,305	1,366	1,328	1,282	1,226	1,132	1,155	1,237	1,015	1,038
Total Revenue	1,642	1,525	1,584	1,533	1,488	1,439	1,338	1,360	1,442	1,208	1,228
Operating Revenue	1,642	1,525	1,584	1,533	1,488	1,439	1,338	1,360	1,442	1,208	1,228
Total Cost of Revenue	207	221	219	205	206	213	206	206	205	193	190
Operating Cost of Revenue	207	221	219	205	206	213	206	206	205	193	190
Total Operating Expenses	328	357	341	327	322	363	312	316	323	347	299
Selling, General & Admin Expense	83	124	93	93	90	138	89	95	99	134	79
Depreciation Expense	27	28	28	29	30	31	31	32	32	34	35
Amortization Expense	55	55	56	56	55	56	57	57	57	57	56
Other Operating Expenses / (Income)	162	150	164	150	147	139	135	132	136	122	130
Total Other Income / (Expense), net	137	150	153	154	154	143	154	178	243	159	141
Interest Expense	42	41	40	40	40	40	40	40	40	40	40
Interest & Investment Income	981	1,028	1,113	1,131	1,159	1,144	1,349	1,643	1,436	1,216	763
Other Income / (Expense), net	-802	-838	-920	-937	-965	-961	-1,156	-1,425	-1,153	-1,017	-581
Income Tax Expense	289	222	264	271	258	191	224	239	273	189	200
Basic Earnings per Share	$2.63	$2.40	$2.51	$2.43	$2.35	$2.24	$2.06	$2.14	$2.43	$1.76	$1.87
Weighted Average Basic Shares Outstanding	359.61M	359.39M	359.40M	359.33M	359.26M	359.02M	359.02M	358.94M	358.93M	358.71M	358.72M
Diluted Earnings per Share	$2.62	$2.40	$2.50	$2.42	$2.35	$2.23	$2.06	$2.14	$2.43	$1.76	$1.87
Weighted Average Diluted Shares Outstanding	360.23M	359.94M	359.99M	359.87M	359.83M	359.50M	359.62M	359.43M	359.31M	359.18M	359.29M
Weighted Average Basic & Diluted Shares Outstanding	360.36M	360.36M	360.36M	720.19M	720.13M	359.99M	719.99M	719.50M	359.72M	359.72M	359.73M
Cash Dividends to Common per Share	$1.25	-	$1.15	$1.15	$1.15	-	$1.10	$1.10	$1.10	-	$1.00

This table details how cash moves in and out of CME Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	8,684	-44,865	-22,816	72,370	49,787	-2,199	-529	-54	165	327
Net Cash From Operating Activities	3,691	3,454	3,056	2,402	2,716	2,673	2,441	-1,751	1,732	1,533
Net Cash From Continuing Operating Activities	3,691	3,454	3,056	2,402	2,716	2,673	2,441	1,751	1,732	1,524
Net Income / (Loss) Continuing Operations	3,526	3,226	2,691	2,637	2,106	2,116	1,964	4,063	1,534	1,247
Consolidated Net Income / (Loss)	3,526	3,226	2,691	2,637	2,106	2,116	1,964	4,063	1,534	1,247
Depreciation Expense	115	126	135	148	153	159	119	113	129	129
Amortization Expense	222	227	228	238	311	315	130	96	96	99
Non-Cash Adjustments To Reconcile Net Income	83	-64	56	-438	129	104	10	-2,415	43	189
Changes in Operating Assets and Liabilities, net	-255	-61	-54	-182	16	-21	226	-105	-70	-132
Net Cash From Investing Activities	-83	21	-490	58	-176	-153	-1,890	180	54	18
Net Cash From Continuing Investing Activities	-83	21	-490	58	-176	-153	-1,890	180	54	18
Purchase of Property, Plant & Equipment	-94	-76	-90	-127	-198	-246	-117	-82	-92	-114
Acquisitions	0.00	0.00	-410	-53	0.00	0.00	-1,795	0.00	0.00	-
Purchase of Investments	-8.10	-6.50	-7.50	-12	-17	-15	-10	-8.30	-55	-45
Sale and/or Maturity of Investments	20	104	17	111	39	108	12	2.50	192	177
Net Cash From Financing Activities	5,077	-48,339	-25,382	69,909	47,247	-4,719	-1,080	-1,985	-1,621	-1,224
Net Cash From Continuing Financing Activities	5,077	-48,339	-25,382	69,909	47,247	-4,719	-1,080	-1,985	-1,621	-1,224
Repayment of Debt	-9.20	-26	-764	-3.10	-2.20	-624	-437	40	2.20	-671
Payment of Dividends	-3,584	-3,236	-2,634	-2,189	-2,110	-1,696	-2,150	-1,994	-1,787	-1,343
Issuance of Debt	0.00	0.00	741	0.00	-305	-	387	0.00	0.00	744
Other Financing Activities, net	8,670	-45,078	-22,725	71,136	49,663	-2,399	-65	-31	165	47
Cash Interest Paid	130	130	133	133	133	146	108	85	85	89
Cash Income Taxes Paid	1,198	1,109	973	755	653	591	577	763	707	717

This table details how cash moves in and out of CME Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	20,312	8.50	14,321	-8,451	2,806	3,612	-25,630	-14,534	-8,313	-4,135	1,795
Net Cash From Operating Activities	1,117	1,018	1,003	777	893	1,044	857	650	902	982	658
Net Cash From Continuing Operating Activities	1,117	1,018	1,003	777	893	1,044	857	650	902	982	658
Net Income / (Loss) Continuing Operations	956	875	913	883	855	815	750	778	884	638	680
Consolidated Net Income / (Loss)	956	875	913	883	855	815	750	778	884	638	680
Depreciation Expense	27	28	28	29	30	31	31	32	32	34	35
Amortization Expense	55	55	56	56	55	56	57	57	57	57	56
Non-Cash Adjustments To Reconcile Net Income	24	38	30	-8.50	24	-73	37	10	-39	2.60	12
Changes in Operating Assets and Liabilities, net	54	22	-23	-182	-72	216	-19	-227	-31	250	-124
Net Cash From Investing Activities	-16	-25	-30	-5.00	-23	-20	-20	78	-17	-26	-24
Net Cash From Continuing Investing Activities	-16	-25	-30	-5.00	-23	-20	-20	78	-17	-26	-24
Purchase of Property, Plant & Equipment	-14	-26	-30	-18	-20	-21	-20	-21	-15	-24	-24
Purchase of Investments	-5.40	-0.20	-1.30	-1.90	-4.70	-1.10	-0.40	-2.30	-2.70	-2.70	-0.80
Sale and/or Maturity of Investments	3.60	1.10	1.60	15	1.70	1.50	0.80	101	0.70	1.40	1.20
Net Cash From Financing Activities	19,211	-984	13,347	-9,223	1,936	2,589	-26,467	-15,263	-9,199	-5,091	1,161
Net Cash From Continuing Financing Activities	19,211	-984	13,347	-9,223	1,936	2,589	-26,467	-15,263	-9,199	-5,091	1,161
Repayment of Debt	-754	-0.20	-4.40	-0.30	-4.30	-8.90	-	-13	-4.10	1.00	-4.30
Payment of Dividends	-2,567	-419	-419	-419	-2,328	-400	-400	-400	-2,036	-364	-363
Issuance of Debt	742	-	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	21,791	-565	13,770	-8,804	4,269	2,998	-26,067	-14,850	-7,159	-4,729	1,528
Cash Interest Paid	41	24	41	24	41	24	41	24	41	25	41
Cash Income Taxes Paid	13	259	289	535	115	226	272	581	31	169	325

This table presents CME Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	137,447	129,706	174,176	196,780	124,660	75,215	77,476	75,791	69,369	67,359
Total Current Assets	103,034	94,890	139,078	161,762	89,284	39,568	41,887	46,907	40,032	37,905
Cash & Equivalents	2,892	2,912	2,720	2,835	1,633	1,551	1,375	1,904	1,869	1,693
Short-Term Investments	113	112	96	115	101	83	73	90	83	73
Accounts Receivable	573	536	483	435	461	492	553	360	364	358
Other Current Assets	99,455	91,331	135,779	158,377	87,089	37,441	39,886	44,553	37,715	35,782
Plant, Property, & Equipment, net	386	410	456	505	579	544	449	400	425	492
Total Noncurrent Assets	34,027	34,406	34,642	34,513	34,797	35,104	35,140	28,485	28,913	28,963
Goodwill	10,487	10,495	10,483	10,528	10,799	10,743	10,805	7,569	7,569	7,569
Intangible Assets	19,997	20,226	20,445	20,707	17,175	22,293	22,675	19,522	19,617	19,713
Other Noncurrent Operating Assets	3,544	3,686	3,714	3,278	1,957	2,068	1,660	1,394	1,727	1,681
Total Liabilities & Shareholders' Equity	137,447	129,706	174,176	196,780	124,660	75,215	77,476	75,791	69,369	67,359
Total Liabilities	110,960	102,968	147,297	169,381	98,308	49,056	51,510	53,379	49,029	46,808
Total Current Liabilities	102,314	93,417	137,688	160,398	88,198	38,523	41,273	45,673	38,946	36,825
Short-Term Debt	750	0.00	16	749	0.00	-	574	0.00	-	-
Accounts Payable	80	91	121	49	69	62	116	31	26	29
Other Current Liabilities	101,484	93,326	137,550	159,600	88,129	38,461	40,582	45,642	38,919	36,796
Total Noncurrent Liabilities	8,646	9,551	9,610	8,983	10,110	10,534	10,238	7,707	10,083	9,983
Long-Term Debt	2,678	3,425	3,422	2,696	3,444	3,743	3,827	2,233	2,231	2,229
Noncurrent Deferred & Payable Income Tax Liabilities	5,247	5,328	5,361	5,390	5,607	5,635	5,666	4,858	7,291	7,358
Other Noncurrent Operating Liabilities	721	798	826	897	1,059	1,155	745	616	561	396
Total Equity & Noncontrolling Interests	26,487	26,738	26,879	27,399	26,352	26,159	25,965	22,412	20,341	20,552
Total Preferred & Common Equity	26,487	26,738	26,879	27,399	26,320	26,129	25,919	22,412	20,341	20,552
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	26,487	26,738	26,879	27,399	26,320	26,129	25,919	22,412	20,341	20,552
Common Stock	22,407	22,338	22,265	22,194	21,189	21,117	21,058	17,900	17,830	17,725
Retained Earnings	4,186	4,455	4,747	5,152	4,996	5,009	4,855	4,497	2,525	2,908
Accumulated Other Comprehensive Income / (Loss)	-106	-56	-133	54	135	3.40	5.30	14	-14	-81

This table presents CME Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	157,832	137,447	137,795	123,379	132,054	129,706	125,598	151,297	166,039	174,176	178,432
Total Current Assets	123,445	103,034	103,143	88,749	97,308	94,890	90,777	116,366	131,032	139,078	143,253
Cash & Equivalents	1,405	2,892	2,322	1,790	1,437	2,912	2,300	1,880	1,565	2,720	2,130
Short-Term Investments	114	113	112	122	121	112	104	107	105	96	91
Accounts Receivable	770	573	629	600	628	536	558	599	724	483	580
Other Current Assets	121,156	99,455	100,079	86,238	95,122	91,331	87,814	113,780	128,638	135,779	140,451
Plant, Property, & Equipment, net	371	386	386	385	396	410	417	430	440	456	466
Total Noncurrent Assets	34,015	34,027	34,266	34,246	34,350	34,406	34,404	34,501	34,567	34,642	34,713
Goodwill	10,500	10,487	10,514	10,489	10,490	10,495	10,478	10,491	10,491	10,483	10,447
Intangible Assets	19,949	19,997	20,068	20,108	20,165	20,226	20,271	20,336	20,393	20,445	20,478
Other Noncurrent Operating Assets	3,567	3,544	3,685	3,650	3,695	3,686	3,656	3,674	3,684	3,714	3,788
Total Liabilities & Shareholders' Equity	157,832	137,447	137,795	123,379	132,054	129,706	125,598	151,297	166,039	174,176	178,432
Total Liabilities	130,801	110,960	109,579	95,744	104,900	102,968	97,447	123,479	138,655	147,297	150,181
Total Current Liabilities	121,420	102,314	100,822	86,974	96,101	93,417	87,881	113,886	129,044	137,688	140,573
Short-Term Debt	0.00	750	750	750	749	0.00	0.00	0.00	16	16	15
Accounts Payable	100	80	130	100	111	91	54	51	97	121	95
Other Current Liabilities	121,320	101,484	99,942	86,125	95,241	93,326	87,827	113,835	128,930	137,550	140,463
Total Noncurrent Liabilities	9,381	8,646	8,757	8,770	8,798	9,551	9,566	9,593	9,611	9,610	9,608
Long-Term Debt	3,419	2,678	2,678	2,677	2,677	3,425	3,425	3,424	3,423	3,422	3,422
Noncurrent Deferred & Payable Income Tax Liabilities	5,240	5,247	5,310	5,309	5,317	5,328	5,333	5,344	5,357	5,361	5,352
Other Noncurrent Operating Liabilities	721	721	769	783	804	798	809	826	831	826	835
Total Equity & Noncontrolling Interests	27,031	26,487	28,216	27,636	27,154	26,738	28,152	27,818	27,384	26,879	28,251
Total Preferred & Common Equity	27,031	26,487	28,216	27,636	27,154	26,738	28,152	27,818	27,384	26,879	28,251
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	27,031	26,487	28,216	27,636	27,154	26,738	28,152	27,818	27,384	26,879	28,251
Common Stock	22,420	22,407	22,379	22,376	22,349	22,338	22,313	22,311	22,285	22,265	22,239
Retained Earnings	4,686	4,186	5,848	5,355	4,891	4,455	5,956	5,607	5,230	4,747	6,112
Accumulated Other Comprehensive Income / (Loss)	-75	-106	-11	-95	-86	-56	-117	-100	-131	-133	-100

This table displays calculated financial ratios and metrics derived from CME Group's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.88%	11.15%	7.03%	-3.97%	0.32%	12.96%	18.24%	1.38%	8.07%	6.89%
EBITDA Growth	167.19%	-159.80%	-55.05%	13.22%	17.94%	10.49%	4.35%	-8.12%	9.74%	8.45%
EBIT Growth	121.62%	-209.16%	-61.39%	18.80%	22.51%	0.75%	2.78%	-8.18%	11.06%	9.82%
NOPAT Growth	14.38%	14.77%	12.46%	1.31%	0.25%	10.43%	-50.40%	151.85%	16.44%	12.65%
Net Income Growth	9.29%	19.89%	2.05%	25.19%	-50.22%	115.66%	-51.71%	164.87%	23.02%	10.66%
EPS Growth	9.14%	19.73%	1.51%	24.19%	-0.68%	3.50%	-52.18%	163.58%	22.76%	10.15%
Operating Cash Flow Growth	6.85%	13.02%	27.21%	-11.53%	1.60%	9.51%	239.39%	-201.10%	13.02%	18.67%
Free Cash Flow Firm Growth	8.34%	11.45%	203.33%	-136.99%	164.74%	160.73%	-362.53%	-9.96%	1.62%	81.67%
Invested Capital Growth	-0.85%	-1.31%	-1.41%	20.26%	-17.94%	-2.25%	27.67%	9.85%	-1.88%	-2.66%
Revenue Q/Q Growth	1.42%	4.33%	1.22%	1.05%	-0.81%	-1.98%	8.47%	-0.35%	2.83%	-0.81%
EBITDA Q/Q Growth	50.62%	21.39%	-41.12%	5.67%	1.00%	0.11%	4.82%	-4.49%	2.58%	-0.11%
EBIT Q/Q Growth	320.87%	16.62%	-47.77%	7.44%	1.00%	-1.04%	3.29%	-4.66%	2.78%	-0.12%
NOPAT Q/Q Growth	1.88%	7.33%	0.89%	4.35%	-1.03%	2.77%	-56.11%	173.29%	3.01%	-0.98%
Net Income Q/Q Growth	1.73%	5.79%	0.47%	8.22%	-50.63%	108.22%	-56.55%	171.33%	5.63%	-1.17%
EPS Q/Q Growth	1.79%	5.60%	0.96%	7.52%	-2.17%	4.05%	-56.94%	170.75%	5.35%	-1.07%
Operating Cash Flow Q/Q Growth	-0.71%	1.85%	11.42%	0.33%	-2.14%	8.50%	319.61%	-197.81%	6.67%	-6.77%
Free Cash Flow Firm Q/Q Growth	10.94%	8.99%	270.31%	-148.32%	192.67%	222.71%	-1,358.48%	-14.64%	20.59%	11.45%
Invested Capital Q/Q Growth	-7.87%	-6.97%	-6.67%	9.11%	-20.09%	-3.84%	14.64%	5.96%	-6.24%	-4.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	86.13%	85.15%	85.00%	82.15%	82.46%	81.54%	81.68%	84.53%	84.89%	79.64%
EBITDA Margin	9.94%	-16.25%	30.20%	71.93%	61.01%	51.89%	53.05%	60.11%	66.32%	65.31%
Operating Margin	64.13%	61.58%	60.08%	56.40%	54.01%	53.16%	60.51%	63.40%	61.21%	59.78%
EBIT Margin	4.44%	-22.57%	22.98%	63.71%	51.50%	42.17%	47.28%	54.39%	60.06%	58.44%
Profit (Net Income) Margin	57.52%	57.83%	53.61%	56.23%	43.13%	86.93%	45.53%	111.49%	42.67%	37.48%
Tax Burden Percent	77.64%	77.67%	77.10%	78.16%	77.38%	157.33%	70.64%	160.84%	67.06%	63.73%
Interest Burden Percent	1,667.79%	-329.86%	302.58%	112.91%	108.23%	131.01%	136.33%	127.44%	105.95%	100.65%
Effective Tax Rate	22.36%	22.33%	22.90%	21.84%	22.62%	21.33%	29.31%	-60.84%	32.94%	36.27%
Return on Invested Capital (ROIC)	11.29%	9.77%	8.40%	8.09%	7.93%	7.12%	7.15%	17.18%	7.09%	5.95%
ROIC Less NNEP Spread (ROIC-NNEP)	126.21%	118.68%	73.86%	-34.71%	-4.59%	93.88%	14.59%	150.95%	22.80%	2.36%
Return on Net Nonoperating Assets (RNNOA)	1.95%	2.27%	1.52%	1.72%	0.09%	9.12%	0.96%	1.83%	0.41%	0.06%
Return on Equity (ROE)	13.25%	12.03%	9.92%	9.81%	8.02%	16.24%	8.11%	19.01%	7.50%	6.01%
Cash Return on Invested Capital (CROIC)	12.15%	11.09%	9.82%	-10.30%	27.64%	9.40%	-17.16%	7.79%	8.99%	8.65%
Operating Return on Assets (OROA)	0.20%	-0.83%	0.62%	1.86%	2.52%	2.69%	2.66%	2.73%	3.16%	2.79%
Return on Assets (ROA)	2.64%	2.12%	1.45%	1.64%	2.11%	5.54%	2.56%	5.60%	2.24%	1.79%
Return on Common Equity (ROCE)	13.25%	12.03%	9.92%	9.81%	8.01%	16.21%	8.10%	19.01%	7.50%	6.01%
Return on Equity Simple (ROE_SIMPLE)	13.31%	12.07%	10.01%	9.62%	8.00%	16.20%	7.57%	18.13%	7.54%	6.07%
Net Operating Profit after Tax (NOPAT)	3,052	2,669	2,325	2,068	2,041	2,036	1,843	3,716	1,476	1,267
NOPAT Margin	49.79%	47.83%	46.33%	44.09%	41.79%	41.82%	42.78%	101.97%	41.05%	38.09%
Net Nonoperating Expense Percent (NNEP)	-114.92%	-108.91%	-65.46%	42.80%	12.52%	-86.76%	-7.44%	-133.77%	-15.71%	3.59%
Return On Investment Capital (ROIC_SIMPLE)	10.20%	8.85%	7.67%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	13.87%	14.85%	15.00%	17.85%	17.54%	18.46%	18.32%	15.47%	15.11%	20.36%
SG&A Expenses to Revenue	6.53%	7.54%	7.55%	8.37%	9.87%	10.98%	11.44%	8.61%	10.93%	7.43%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.99%	23.56%	24.91%	25.75%	28.46%	28.38%	21.17%	21.13%	23.68%	19.86%
Earnings before Interest and Taxes (EBIT)	272	-1,259	1,154	2,988	2,515	2,053	2,038	1,982	2,159	1,944
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	609	-907	1,516	3,373	2,979	2,526	2,286	2,191	2,384	2,173
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.16	2.71	2.05	2.70	2.17	2.33	2.03	1.78	1.48	1.09
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	13.65	12.98	10.98	15.76	11.68	12.49	12.23	10.93	8.35	6.71
Price to Earnings (P/E)	24.04	22.74	20.74	28.25	27.09	14.36	26.89	9.80	19.57	17.91
Dividend Yield	4.48%	4.80%	5.55%	3.33%	3.71%	3.24%	2.94%	5.25%	6.39%	7.42%
Earnings Yield	4.16%	4.40%	4.82%	3.54%	3.69%	6.96%	3.72%	10.20%	5.11%	5.58%
Enterprise Value to Invested Capital (EV/IC)	3.13	2.68	2.03	2.67	2.53	2.23	1.93	1.77	1.47	1.09
Enterprise Value to Revenue (EV/Rev)	13.72	13.06	11.11	15.87	12.04	12.93	12.93	11.00	8.43	6.85
Enterprise Value to EBITDA (EV/EBITDA)	138.09	0.00	36.77	22.06	19.73	24.91	24.37	18.29	12.71	10.50
Enterprise Value to EBIT (EV/EBIT)	308.88	0.00	48.33	24.91	23.37	30.66	27.35	20.22	14.03	11.73
Enterprise Value to NOPAT (EV/NOPAT)	27.56	27.30	23.97	36.00	28.80	30.91	30.23	10.78	20.53	17.99
Enterprise Value to Operating Cash Flow (EV/OCF)	22.79	21.09	18.24	30.98	21.64	23.55	22.83	0.00	17.49	14.88
Enterprise Value to Free Cash Flow (EV/FCFF)	25.62	24.04	20.50	0.00	8.26	23.42	0.00	23.78	16.19	12.38
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.13	0.13	0.13	0.13	0.13	0.14	0.17	0.10	0.11	0.11
Long-Term Debt to Equity	0.10	0.13	0.13	0.10	0.13	0.14	0.15	0.10	0.11	0.11
Financial Leverage	0.02	0.02	0.02	-0.05	-0.02	0.10	0.07	0.01	0.02	0.03
Leverage Ratio	5.02	5.67	6.83	5.98	3.81	2.93	3.17	3.40	3.34	3.37
Compound Leverage Factor	83.71	-18.70	20.68	6.75	4.12	3.84	4.32	4.33	3.54	3.39
Debt to Total Capital	11.46%	11.36%	11.34%	11.17%	11.56%	12.52%	14.49%	9.06%	9.88%	9.79%
Short-Term Debt to Total Capital	2.51%	0.00%	0.05%	2.43%	0.00%	0.00%	1.89%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	8.95%	11.36%	11.29%	8.74%	11.56%	12.52%	12.60%	9.06%	9.88%	9.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.11%	0.10%	0.15%	0.00%	0.00%	0.00%
Common Equity to Total Capital	88.54%	88.64%	88.66%	88.83%	88.34%	87.38%	85.35%	90.94%	90.12%	90.21%
Debt to EBITDA	5.63	-3.78	2.27	1.02	1.16	1.48	1.92	1.02	0.94	1.03
Net Debt to EBITDA	0.69	-0.44	0.41	0.15	0.57	0.83	1.29	0.11	0.12	0.21
Long-Term Debt to EBITDA	4.40	-3.78	2.26	0.80	1.16	1.48	1.67	1.02	0.94	1.03
Debt to NOPAT	1.12	1.28	1.48	1.67	1.69	1.84	2.39	0.60	1.51	1.76
Net Debt to NOPAT	0.14	0.15	0.27	0.24	0.84	1.04	1.60	0.06	0.19	0.37
Long-Term Debt to NOPAT	0.88	1.28	1.47	1.30	1.69	1.84	2.08	0.60	1.51	1.76
Altman Z-Score	0.55	0.49	0.32	0.38	0.52	1.01	0.85	0.68	0.59	0.51
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.06%	0.12%	0.15%	0.10%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.01	1.02	1.01	1.01	1.01	1.03	1.01	1.03	1.03	1.03
Quick Ratio	0.04	0.04	0.02	0.02	0.02	0.06	0.05	0.05	0.06	0.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3,283	3,030	2,719	-2,631	7,113	2,687	-4,424	1,685	1,872	1,842
Operating Cash Flow to CapEx	3,926.06%	4,520.68%	3,406.91%	2,733.11%	1,374.99%	1,088.27%	2,091.52%	-2,138.10%	1,886.71%	1,341.94%
Free Cash Flow to Firm to Interest Expense	20.40	19.01	16.71	-15.76	42.80	15.09	-28.06	14.40	15.16	15.69
Operating Cash Flow to Interest Expense	22.94	21.67	18.78	14.39	16.34	15.02	15.48	-14.97	14.02	13.05
Operating Cash Flow Less CapEx to Interest Expense	22.35	21.19	18.23	13.87	15.15	13.64	14.74	-15.67	13.28	12.08
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.05	0.04	0.03	0.03	0.05	0.06	0.06	0.05	0.05	0.05
Accounts Receivable Turnover	11.06	10.95	10.94	10.47	10.25	9.32	9.44	10.07	9.96	9.52
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	15.41	12.90	10.45	8.65	8.70	9.81	10.16	8.84	7.84	6.65
Accounts Payable Turnover	9.97	7.82	8.85	14.17	13.06	10.10	10.72	19.61	19.79	20.66
Days Sales Outstanding (DSO)	33.01	33.33	33.37	34.86	35.62	39.18	38.66	36.26	36.66	38.35
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	36.59	46.69	41.24	25.75	27.96	36.13	34.05	18.61	18.44	17.67
Cash Conversion Cycle (CCC)	-3.59	-13.37	-7.88	9.11	7.66	3.05	4.61	17.65	18.22	20.67
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	26,909	27,140	27,501	27,895	23,196	28,268	28,919	22,651	20,620	21,016
Invested Capital Turnover	0.23	0.20	0.18	0.18	0.19	0.17	0.17	0.17	0.17	0.16
Increase / (Decrease) in Invested Capital	-230	-361	-394	4,699	-5,072	-651	6,268	2,031	-396	-575
Enterprise Value (EV)	84,109	72,839	55,743	74,425	58,779	62,933	55,724	40,075	30,296	22,802
Market Capitalization	83,687	72,438	55,121	73,930	57,037	60,794	52,724	39,836	30,016	22,338
Book Value per Share	$73.50	$74.27	$74.72	$76.24	$73.32	$72.91	$76.05	$65.86	$59.94	$60.76
Tangible Book Value per Share	($11.09)	($11.06)	($11.26)	($10.67)	($4.61)	($19.27)	($22.19)	($13.75)	($20.17)	($19.90)
Total Capital	29,915	30,163	30,317	30,844	29,795	29,903	30,366	24,645	22,572	22,781
Total Debt	3,428	3,425	3,438	3,445	3,444	3,743	4,401	2,233	2,231	2,229
Total Long-Term Debt	2,678	3,425	3,422	2,696	3,444	3,743	3,827	2,233	2,231	2,229
Net Debt	422	402	622	495	1,710	2,109	2,954	239	279	464
Capital Expenditures (CapEx)	94	76	90	88	198	246	117	82	92	114
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,536	-1,550	-1,409	-837	-648	-589	-259	-760	-866	-685
Debt-free Net Working Capital (DFNWC)	1,469	1,473	1,407	2,113	1,086	1,045	1,188	1,234	1,086	1,080
Net Working Capital (NWC)	720	1,473	1,391	1,363	1,086	1,045	614	1,234	1,086	1,080
Net Nonoperating Expense (NNE)	-474	-558	-366	-569	-66	-2,196	-119	-347	-58	20
Net Nonoperating Obligations (NNO)	422	402	622	495	-3,156	2,109	2,954	239	279	464
Total Depreciation and Amortization (D&A)	337	353	363	385	464	473	249	209	225	229
Debt-free, Cash-free Net Working Capital to Revenue	-25.06%	-27.79%	-28.08%	-17.85%	-13.27%	-12.11%	-6.01%	-20.85%	-24.09%	-20.59%
Debt-free Net Working Capital to Revenue	23.97%	26.41%	28.03%	45.05%	22.24%	21.47%	27.57%	33.85%	30.20%	32.46%
Net Working Capital to Revenue	11.74%	26.41%	27.71%	29.07%	22.24%	21.47%	14.25%	33.85%	30.20%	32.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$9.69	$8.87	$7.41	$7.30	$5.88	$5.93	$5.73	$12.00	$4.55	$3.71
Adjusted Weighted Average Basic Shares Outstanding	359.39M	359.02M	358.71M	358.34M	357.76M	357.16M	342.34M	338.71M	337.50M	336.22M
Adjusted Diluted Earnings per Share	$9.67	$8.86	$7.40	$7.29	$5.87	$5.91	$5.71	$11.94	$4.53	$3.69
Adjusted Weighted Average Diluted Shares Outstanding	359.94M	359.50M	359.18M	358.93M	358.52M	358.24M	343.74M	340.23M	338.97M	337.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	360.36M	359.99M	359.72M	359.40M	359.01M	358.41M	357.80M	340.39M	339.65M	338.42M
Normalized Net Operating Profit after Tax (NOPAT)	3,052	2,669	2,325	2,068	2,041	2,036	1,843	1,617	1,476	1,267
Normalized NOPAT Margin	49.79%	47.83%	46.33%	44.09%	41.79%	41.82%	42.78%	44.38%	41.05%	38.09%
Pre Tax Income Margin	74.08%	74.45%	69.54%	71.94%	55.74%	55.25%	64.46%	69.31%	63.63%	58.82%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.69	-7.90	7.09	17.90	15.13	11.53	12.92	16.94	17.48	16.56
NOPAT to Interest Expense	18.97	16.74	14.29	12.39	12.28	11.44	11.69	31.76	11.95	10.80
EBIT Less CapEx to Interest Expense	1.11	-8.38	6.54	17.38	13.94	10.15	12.18	16.24	16.74	15.59
NOPAT Less CapEx to Interest Expense	18.39	16.26	13.74	11.86	11.09	10.06	10.95	31.06	11.21	9.82
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	101.66%	100.29%	97.86%	83.03%	100.17%	40.08%	109.57%	49.06%	116.50%	107.73%
Augmented Payout Ratio	101.66%	100.29%	97.86%	83.03%	100.17%	40.08%	109.57%	49.06%	116.50%	107.73%

This table displays calculated financial ratios and metrics derived from CME Group's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.38%	5.98%	18.43%	12.67%	3.21%	19.17%	8.96%	9.94%	7.05%	5.27%	10.62%
EBITDA Growth	384.52%	1,749.57%	176.12%	129.73%	153.26%	95.47%	-199.76%	-179.90%	-116.63%	-132.28%	-75.76%
EBIT Growth	5,976.92%	211.84%	131.07%	110.86%	97.83%	71.92%	-312.68%	-210.20%	-129.43%	-149.44%	-82.96%
NOPAT Growth	15.47%	8.07%	25.78%	19.31%	5.60%	35.64%	10.69%	11.95%	4.71%	4.29%	9.99%
Net Income Growth	11.81%	7.37%	21.67%	13.58%	-3.24%	27.70%	10.39%	17.37%	24.30%	2.03%	-26.63%
EPS Growth	11.49%	7.62%	21.36%	13.08%	-3.29%	26.70%	10.16%	17.58%	24.62%	4.14%	-27.52%
Operating Cash Flow Growth	25.08%	-2.53%	17.08%	19.45%	-1.07%	6.40%	30.24%	5.31%	12.93%	46.87%	4.15%
Free Cash Flow Firm Growth	8.54%	-7.05%	-18.17%	134.34%	129.94%	16.68%	127.78%	-90.72%	-199.99%	121.62%	-183.63%
Invested Capital Growth	-0.31%	-0.85%	0.13%	-0.36%	-0.45%	-1.31%	-1.00%	12.17%	14.08%	-1.41%	15.26%
Revenue Q/Q Growth	7.67%	-3.73%	3.39%	3.00%	3.38%	7.59%	-1.65%	-5.65%	19.36%	-1.63%	-0.76%
EBITDA Q/Q Growth	101.09%	2.61%	27.18%	84.64%	784.62%	95.27%	50.32%	-230.72%	41.80%	-204.32%	-60.21%
EBIT Q/Q Growth	178.83%	5.18%	63.58%	1,325.00%	94.69%	70.78%	42.83%	-145.38%	31.49%	-321.31%	-70.38%
NOPAT Q/Q Growth	12.68%	-4.91%	3.78%	3.85%	5.45%	10.68%	-1.56%	-8.09%	35.46%	-9.68%	-0.44%
Net Income Q/Q Growth	9.33%	-4.18%	3.35%	3.27%	4.98%	8.58%	-3.52%	-12.02%	38.55%	-6.14%	2.58%
EPS Q/Q Growth	9.17%	-4.00%	3.31%	2.98%	5.38%	8.25%	-3.74%	-11.93%	38.07%	-5.88%	2.75%
Operating Cash Flow Q/Q Growth	9.70%	1.49%	29.10%	-12.97%	-14.52%	21.90%	31.72%	-27.93%	-8.06%	49.21%	6.51%
Free Cash Flow Firm Q/Q Growth	-4.38%	30.18%	-12.91%	0.12%	-18.11%	14.60%	136.55%	12.71%	-419.12%	127.29%	-150.91%
Invested Capital Q/Q Growth	7.51%	-7.87%	0.20%	0.44%	6.94%	-6.97%	-0.28%	0.35%	6.01%	-6.67%	12.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	87.41%	85.52%	86.19%	86.64%	86.16%	85.21%	84.64%	84.88%	85.81%	84.02%	84.56%
EBITDA Margin	23.63%	12.65%	11.87%	9.65%	5.38%	-0.81%	-18.47%	-36.57%	-10.43%	-21.39%	20.17%
Operating Margin	67.47%	62.09%	64.64%	65.29%	64.49%	59.97%	61.31%	61.65%	63.38%	55.33%	60.17%
EBIT Margin	18.61%	7.19%	6.58%	4.16%	-0.35%	-6.81%	-25.07%	-43.13%	-16.59%	-28.90%	12.84%
Profit (Net Income) Margin	58.22%	57.34%	57.61%	57.63%	57.48%	56.60%	56.08%	57.17%	61.31%	52.82%	55.35%
Tax Burden Percent	76.82%	79.76%	77.56%	76.50%	76.81%	80.97%	77.00%	76.51%	76.39%	77.11%	77.23%
Interest Burden Percent	407.33%	1,000.55%	1,129.46%	1,812.40%	-21,411.54%	-1,026.53%	-290.49%	-173.24%	-483.86%	-237.05%	558.02%
Effective Tax Rate	23.18%	20.24%	22.44%	23.50%	23.19%	19.03%	23.00%	23.49%	23.61%	22.89%	22.77%
Return on Invested Capital (ROIC)	11.24%	11.23%	10.38%	9.92%	9.58%	9.92%	8.61%	8.93%	9.05%	7.73%	8.38%
ROIC Less NNEP Spread (ROIC-NNEP)	16.82%	40.17%	22.15%	17.89%	16.08%	32.50%	19.23%	-47.40%	-81.09%	29.67%	-35.03%
Return on Net Nonoperating Assets (RNNOA)	1.17%	0.62%	0.79%	0.95%	1.07%	0.62%	0.76%	0.41%	0.61%	0.61%	0.32%
Return on Equity (ROE)	12.41%	11.86%	11.17%	10.87%	10.65%	10.54%	9.37%	9.34%	9.66%	8.34%	8.69%
Cash Return on Invested Capital (CROIC)	11.24%	12.15%	10.14%	10.06%	9.76%	11.09%	9.48%	-2.70%	-4.54%	9.82%	-5.80%
Operating Return on Assets (OROA)	0.81%	0.33%	0.30%	0.18%	-0.01%	-0.25%	-0.88%	-1.38%	-0.46%	-0.78%	0.35%
Return on Assets (ROA)	2.52%	2.63%	2.64%	2.43%	2.17%	2.08%	1.97%	1.83%	1.69%	1.43%	1.50%
Return on Common Equity (ROCE)	12.41%	11.86%	11.17%	10.87%	10.65%	10.54%	9.37%	9.34%	9.66%	8.34%	8.69%
Return on Equity Simple (ROE_SIMPLE)	13.42%	0.00%	12.28%	11.95%	11.78%	0.00%	10.83%	10.71%	10.46%	0.00%	9.48%
Net Operating Profit after Tax (NOPAT)	851	755	794	765	737	699	632	642	698	515	571
NOPAT Margin	51.82%	49.52%	50.14%	49.95%	49.54%	48.56%	47.21%	47.17%	48.42%	42.66%	46.47%
Net Nonoperating Expense Percent (NNEP)	-5.58%	-28.94%	-11.76%	-7.98%	-6.50%	-22.58%	-10.62%	56.33%	90.15%	-21.94%	43.40%
Return On Investment Capital (ROIC_SIMPLE)	2.80%	2.53%	-	-	-	2.32%	-	-	-	1.70%	-
Cost of Revenue to Revenue	12.59%	14.48%	13.81%	13.36%	13.85%	14.79%	15.36%	15.12%	14.19%	15.98%	15.44%
SG&A Expenses to Revenue	5.04%	8.15%	5.89%	6.07%	6.03%	9.59%	6.63%	6.99%	6.85%	11.05%	6.43%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	19.95%	23.43%	21.55%	21.35%	21.66%	25.23%	23.33%	23.22%	22.43%	28.69%	24.39%
Earnings before Interest and Taxes (EBIT)	306	110	104	64	-5.20	-98	-335	-587	-239	-349	158
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	388	193	188	148	80	-12	-247	-497	-150	-258	248
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.54	3.16	2.82	2.56	2.84	2.71	2.44	2.29	2.39	2.05	2.06
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	15.21	13.65	13.15	12.21	13.70	12.98	12.86	12.15	12.78	10.98	11.73
Price to Earnings (P/E)	26.69	24.04	23.20	21.70	24.41	22.74	22.81	21.61	23.10	20.74	21.87
Dividend Yield	3.96%	4.48%	4.44%	4.96%	4.53%	4.80%	4.60%	4.92%	4.73%	5.55%	4.42%
Earnings Yield	3.75%	4.16%	4.31%	4.61%	4.10%	4.40%	4.38%	4.63%	4.33%	4.82%	4.57%
Enterprise Value to Invested Capital (EV/IC)	3.37	3.13	2.75	2.48	2.72	2.68	2.39	2.22	2.30	2.03	2.02
Enterprise Value to Revenue (EV/Rev)	15.51	13.72	13.31	12.47	14.03	13.06	13.05	12.43	13.13	11.11	11.97
Enterprise Value to EBITDA (EV/EBITDA)	106.31	138.09	198.93	0.00	0.00	0.00	0.00	0.00	145.54	36.77	23.06
Enterprise Value to EBIT (EV/EBIT)	167.21	308.88	1,243.41	0.00	0.00	0.00	0.00	0.00	658.34	48.33	26.89
Enterprise Value to NOPAT (EV/NOPAT)	30.79	27.56	26.85	25.52	29.14	27.30	28.08	26.83	28.49	23.97	25.76
Enterprise Value to Operating Cash Flow (EV/OCF)	24.91	22.79	21.64	20.25	22.92	21.09	20.59	20.39	21.25	18.24	21.65
Enterprise Value to Free Cash Flow (EV/FCFF)	29.93	25.62	27.19	24.62	27.79	24.04	25.11	0.00	0.00	20.50	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.13	0.13	0.12	0.12	0.13	0.13	0.12	0.12	0.13	0.13	0.12
Long-Term Debt to Equity	0.13	0.10	0.09	0.10	0.10	0.13	0.12	0.12	0.13	0.13	0.12
Financial Leverage	0.07	0.02	0.04	0.05	0.07	0.02	0.04	-0.01	-0.01	0.02	-0.01
Leverage Ratio	5.35	5.02	4.67	4.95	5.47	5.67	5.39	5.88	6.75	6.83	6.58
Compound Leverage Factor	21.79	50.22	52.78	89.77	-1,170.30	-58.18	-15.66	-10.18	-32.65	-16.20	36.70
Debt to Total Capital	11.23%	11.46%	10.83%	11.03%	11.20%	11.36%	10.85%	10.96%	11.16%	11.34%	10.84%
Short-Term Debt to Total Capital	0.00%	2.51%	2.37%	2.41%	2.45%	0.00%	0.00%	0.00%	0.05%	0.05%	0.05%
Long-Term Debt to Total Capital	11.23%	8.95%	8.46%	8.62%	8.75%	11.36%	10.85%	10.96%	11.11%	11.29%	10.80%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	88.77%	88.54%	89.17%	88.97%	88.80%	88.64%	89.15%	89.04%	88.84%	88.66%	89.16%
Debt to EBITDA	3.73	5.63	8.48	-111.26	-5.07	-3.78	-2.97	-5.20	7.45	2.27	1.33
Net Debt to EBITDA	2.07	0.69	2.46	-49.19	-2.76	-0.44	-0.88	-2.18	3.83	0.41	0.47
Long-Term Debt to EBITDA	3.73	4.40	6.62	-86.92	-3.96	-3.78	-2.97	-5.20	7.42	2.26	1.33
Debt to NOPAT	1.08	1.12	1.14	1.21	1.26	1.28	1.38	1.41	1.46	1.48	1.49
Net Debt to NOPAT	0.60	0.14	0.33	0.53	0.69	0.15	0.41	0.59	0.75	0.27	0.53
Long-Term Debt to NOPAT	1.08	0.88	0.89	0.95	0.99	1.28	1.38	1.41	1.45	1.47	1.48
Altman Z-Score	0.54	0.55	0.56	0.57	0.55	0.52	0.55	0.40	0.37	0.29	0.33
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.02	1.01	1.02	1.02	1.01	1.02	1.03	1.02	1.02	1.01	1.02
Quick Ratio	0.02	0.04	0.03	0.03	0.02	0.04	0.03	0.02	0.02	0.02	0.02
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	943	986	757	869	868	1,060	925	-2,532	-2,900	909	-3,330
Operating Cash Flow to CapEx	7,863.38%	3,885.11%	3,365.77%	4,268.68%	4,508.59%	5,020.67%	4,305.03%	3,172.68%	5,936.84%	4,022.54%	2,740.83%
Free Cash Flow to Firm to Interest Expense	22.60	24.22	18.84	21.68	21.76	26.71	23.36	-62.97	-72.69	22.78	-82.44
Operating Cash Flow to Interest Expense	26.78	25.01	24.95	19.37	22.37	26.30	21.63	16.18	22.62	24.60	16.28
Operating Cash Flow Less CapEx to Interest Expense	26.44	24.37	24.21	18.92	21.88	25.78	21.13	15.67	22.24	23.99	15.69
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.04	0.05	0.05	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03
Accounts Receivable Turnover	8.99	11.06	10.18	9.67	8.32	10.95	9.39	8.86	7.68	10.94	9.44
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	16.38	15.41	15.04	14.23	13.45	12.90	12.11	11.49	10.95	10.45	10.05
Accounts Payable Turnover	8.06	9.97	9.17	11.00	7.97	7.82	10.87	12.03	8.68	8.85	9.18
Days Sales Outstanding (DSO)	40.61	33.01	35.87	37.74	43.86	33.33	38.86	41.18	47.55	33.37	38.66
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	45.29	36.59	39.80	33.19	45.77	46.69	33.58	30.34	42.06	41.24	39.77
Cash Conversion Cycle (CCC)	-4.68	-3.59	-3.93	4.55	-1.92	-13.37	5.28	10.84	5.49	-7.88	-1.10
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	28,931	26,909	29,209	29,151	29,022	27,140	29,172	29,255	29,154	27,501	29,466
Invested Capital Turnover	0.22	0.23	0.21	0.20	0.19	0.20	0.18	0.19	0.19	0.18	0.18
Increase / (Decrease) in Invested Capital	-91	-230	37	-104	-131	-361	-294	3,173	3,598	-394	3,901
Enterprise Value (EV)	97,499	84,109	80,448	72,304	78,929	72,839	69,805	65,075	67,151	55,743	59,379
Market Capitalization	95,599	83,687	79,455	70,789	77,061	72,438	68,784	63,638	65,382	55,121	58,164
Book Value per Share	$75.01	$73.50	$78.36	$76.75	$75.58	$74.27	$78.25	$77.33	$76.13	$74.72	$78.60
Tangible Book Value per Share	($9.48)	($11.09)	($6.57)	($8.22)	($9.74)	($11.06)	($7.22)	($8.36)	($9.73)	($11.26)	($7.44)
Total Capital	30,450	29,915	31,644	31,063	30,580	30,163	31,576	31,242	30,824	30,317	31,687
Total Debt	3,419	3,428	3,427	3,427	3,426	3,425	3,425	3,424	3,439	3,438	3,436
Total Long-Term Debt	3,419	2,678	2,678	2,677	2,677	3,425	3,425	3,424	3,423	3,422	3,422
Net Debt	1,900	422	993	1,515	1,868	402	1,020	1,437	1,769	622	1,215
Capital Expenditures (CapEx)	14	26	30	18	20	21	20	21	15	24	24
Debt-free, Cash-free Net Working Capital (DFCFNWC)	506	-1,536	636	613	398	-1,550	492	494	334	-1,409	473
Debt-free Net Working Capital (DFNWC)	2,025	1,469	3,071	2,524	1,956	1,473	2,896	2,480	2,004	1,407	2,695
Net Working Capital (NWC)	2,025	720	2,321	1,775	1,206	1,473	2,896	2,480	1,988	1,391	2,680
Net Nonoperating Expense (NNE)	-105	-119	-118	-118	-118	-116	-119	-136	-186	-123	-109
Net Nonoperating Obligations (NNO)	1,900	422	993	1,515	1,868	402	1,020	1,437	1,769	622	1,215
Total Depreciation and Amortization (D&A)	83	83	84	84	85	86	88	89	89	91	90
Debt-free, Cash-free Net Working Capital to Revenue	8.05%	-25.06%	10.53%	10.56%	7.07%	-27.79%	9.20%	9.42%	6.53%	-28.08%	9.54%
Debt-free Net Working Capital to Revenue	32.23%	23.97%	50.80%	43.54%	34.77%	26.41%	54.16%	47.36%	39.19%	28.03%	54.34%
Net Working Capital to Revenue	32.23%	11.74%	38.40%	30.61%	21.44%	26.41%	54.16%	47.36%	38.87%	27.71%	54.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.63	$2.40	$2.51	$2.43	$2.35	$2.24	$2.06	$2.14	$2.43	$1.76	$1.87
Adjusted Weighted Average Basic Shares Outstanding	359.61M	359.39M	359.40M	359.33M	359.26M	359.02M	359.02M	358.94M	358.93M	358.71M	358.72M
Adjusted Diluted Earnings per Share	$2.62	$2.40	$2.50	$2.42	$2.35	$2.23	$2.06	$2.14	$2.43	$1.76	$1.87
Adjusted Weighted Average Diluted Shares Outstanding	360.23M	359.94M	359.99M	359.87M	359.83M	359.50M	359.62M	359.43M	359.31M	359.18M	359.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	360.36M	360.36M	360.36M	720.19M	720.13M	359.99M	719.99M	719.50M	359.72M	359.72M	359.73M
Normalized Net Operating Profit after Tax (NOPAT)	851	755	794	765	737	699	632	642	698	515	571
Normalized NOPAT Margin	51.82%	49.52%	50.14%	49.95%	49.54%	48.56%	47.21%	47.17%	48.42%	42.66%	46.47%
Pre Tax Income Margin	75.80%	71.89%	74.28%	75.33%	74.83%	69.90%	72.83%	74.72%	80.25%	68.50%	71.67%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.33	2.69	2.59	1.59	-0.13	-2.47	-8.47	-14.59	-5.99	-8.75	3.90
NOPAT to Interest Expense	20.41	18.56	19.76	19.09	18.47	17.61	15.95	15.96	17.49	12.91	14.12
EBIT Less CapEx to Interest Expense	6.99	2.05	1.85	1.13	-0.63	-2.99	-8.97	-15.10	-6.37	-9.36	3.31
NOPAT Less CapEx to Interest Expense	20.07	17.92	19.02	18.64	17.98	17.08	15.45	15.45	17.11	12.30	13.53
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	105.42%	101.66%	102.88%	107.38%	110.34%	100.29%	104.90%	106.15%	109.14%	97.86%	96.96%
Augmented Payout Ratio	105.42%	101.66%	102.88%	107.38%	110.34%	100.29%	104.90%	106.15%	109.14%	97.86%	96.96%

Frequently Asked Questions About CME Group's Financials

When does CME Group's financial year end?

According to the most recent income statement we have on file, CME Group's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CME Group's net income changed over the last 9 years?

CME Group's net income appears to be on an upward trend, with a most recent value of $3.53 billion in 2024, rising from $1.25 billion in 2015. The previous period was $3.23 billion in 2023. Check out CME Group's forecast to explore projected trends and price targets.

What is CME Group's operating income?

CME Group's total operating income in 2024 was $3.93 billion, based on the following breakdown:

Total Gross Profit: $5.28 billion
Total Operating Expenses: $1.35 billion

How has CME Group revenue changed over the last 9 years?

Over the last 9 years, CME Group's total revenue changed from $3.33 billion in 2015 to $6.13 billion in 2024, a change of 84.3%.

How much debt does CME Group have?

CME Group's total liabilities were at $110.96 billion at the end of 2024, a 7.8% increase from 2023, and a 137.1% increase since 2015.

How much cash does CME Group have?

In the past 9 years, CME Group's cash and equivalents has ranged from $1.37 billion in 2018 to $2.91 billion in 2023, and is currently $2.89 billion as of their latest financial filing in 2024.

How has CME Group's book value per share changed over the last 9 years?

Over the last 9 years, CME Group's book value per share changed from 60.76 in 2015 to 73.50 in 2024, a change of 21.0%.

Related Companies

This page (NASDAQ:CME) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CME Group (CME) Financials

Frequently Asked Questions About CME Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CME Group (CME) Financials

Annual Income Statements for CME Group

Quarterly Income Statements for CME Group

Annual Cash Flow Statements for CME Group

Quarterly Cash Flow Statements for CME Group

Annual Balance Sheets for CME Group

Quarterly Balance Sheets for CME Group

Annual Metrics And Ratios for CME Group

Quarterly Metrics And Ratios for CME Group

Frequently Asked Questions About CME Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools